Liver Cirrhosis, Biliary

• 

  Subject Areas on Research

  • Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. 
  • Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. 
  • Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways. 
  • Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Co-occurrence of idiopathic granulomatous hepatitis and primary biliary cirrhosis. 
  • Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. 
  • Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. 
  • Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. 
  • Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis. 
  • Non-parametric estimation of a time-dependent predictive accuracy curve. 
  • Noninvasive markers in the assessment and management of autoimmune liver diseases. 
  • Primary biliary cirrhosis: new therapeutic directions. 
  • Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. 
  • Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. 
  • Score and deviance residuals based on the full likelihood approach in survival analysis. 
  • Surgical portosystemic shunts for treatment of portal hypertensive bleeding: outcome and effect on liver function. 
  • Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis. 
  • Takotsubo cardiomyopathy in a liver transplant recipient: a diagnosis of exclusion? 
  • The binding of SLE autoantibodies to mitochondria. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The pathology of primary biliary cirrhosis. 
  • Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. 
• 

  Keywords of People

  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology